CTRI/2022/01/039493CompletedPhase 4
Clinical Study to assess the Efficacy and Safety of Haridradya Taila in Acne and Acne-induced Post-inflammatory Hyperpigmentation
Ms Ozone Pharmaceuticals Ltd0 sites50 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients of either sex having mild to moderate facial Acne and mild to moderate acne induced PIH in clinical features.
- •Ã¯â??· Patients of age between 18 - 45 years.
- •Ã¯â??· Willing to take part in study and signing consent form
Exclusion Criteria
- •1. With Present History of Skin Disease e.g. Psoriasis, Dermatitis, Vitiligo etc. related to face.
- •2. Person suffering from any infective or contagious skin disease
- •3. Under medication with antibiotics, antifungal and steroid during last one month.
- •4. Women on Oral contraceptives
- •5. Patients of known uncontrolled hormonal disease.
- •6. Any kind of diagnosed hereditary skin disorder.
- •7. Patient who had undergone any type of skin treatment like laser therapy in last 6 months
Investigators
Similar Trials
Completed
Phase 2
A Clinical Evaluation of Piloset Tablet Piloset Cream in Patients suffering from Internal Hemorrhoids.CTRI/2014/01/004300ARJUN HEALTHCARE30
Not yet recruiting
Phase 2
Clinical study of Softovac Liquifibre in constipatioCTRI/2023/03/051094upin Limited
Completed
Phase 2
A Clinical study of Ostofix Tablet in subjects suffering from Osteoarthritis of Knee(s)CTRI/2014/02/004373ARJUN HEALTHCARE36
Completed
Phase 3
A Clinical trial to study effect of Ayulax Capsule in the Management of Functional ConstipatioCTRI/2015/01/005349Welex Laboratories Pvt Ltd36
Recruiting
Phase 2
A Clinical study on Amal Tablets in constipatioCTRI/2023/07/055837SANDOOK SUTRAS PVT LTD